Diagnosis, management, and future developments of fibromuscular dysplasia

Journal of Vascular Surgery

Volumn 53, Issue 3, 2011, Pages

  Olin, Jeffrey W ^a   Sealove, Brett A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT THERAPY; ARTERY DISSECTION; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CAROTID ARTERY; CLINICAL FEATURE; CONVENTIONAL ANGIOGRAPHY; DIFFERENTIAL DIAGNOSIS; FIBROMUSCULAR DYSPLASIA; HUMAN; HYPERTENSION; KIDNEY ARTERY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVIEW; STROKE; TRANSIENT ISCHEMIC ATTACK; VASCULITIS; VERTEBRAL ARTERY;

EID: 79951960521     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.10.066     Document Type: Article

References (96)

1. Leadbetter WF, Burkland CE. Hypertension in unilateral renal disease. J Urol 1938;39:611-26.
2. McCormack LJ, Hazard JB, Poutasse EF. Obstructive lesions of the renal artery associated with remediable hypertension. Am Jr Pathol 1938;34:582.
3. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004;350: 1862-71.
4. Olin JW, Pierce M. Contemporary management of fibromuscular dysplasia. Curr Opin Cardiol 2008;23:527-36.
5. Pascual A, Bush HS, Copley JB. Renal fibromuscular dysplasia in elderly persons. Am J Kidney Dis 2005;45:e63-6.
6. Stanley JC, Zelenock GB, Messina LM, Wakefield TW. Pediatric renovascular hypertension: a thirty-year experience of operative treatment. J Vasc Surg 1995;21:212-26.
7. Cragg AH, Smith TP, Thompson BH, Maroney TP, Stanson AW, Shaw GT, et al. Incidental fibromuscular dysplasia in potential renal donors: long-term clinical follow-up. Radiology 1989;172:145-7. (Pubitemid 19192497)
8. Blondin D, Lanzman R, Schellhammer F, Oels M, Grotemeyer D, Baldus SE, et al. Fibromuscular dysplasia in living renal donors: still a challenge to computed tomographic angiography. Eur J Radiol 2009; 75:67-71.
9. Neymark E, LaBerge JM, Hirose R, Melzer JS, Kerlan RK Jr, Wilson MW, et al. Arteriographic detection of renovascular disease in potential renal donors: incidence and effect on donor surgery. Radiology 2000; 214:755-60. (Pubitemid 30115376)
10. Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke 1982;13:46-52.
11. Stanley JC, Gewertz BL, Bove EL, Sottiurai V, Fry WJ. Arterial fibrodysplasia. Histopathologic character and current etiologic concepts. Arch Surg 1975;110:561-6.
12. Harrison EG Jr, Hunt JC, Bernatz PE. Morphology of fibromuscular dysplasia of the renal artery in renovascular hypertension. Am J Med 1967;43:97-112.
13. Altit R, Brown DB, Gardiner GA. Renal artery aneurysm and arteriovenous fistula associated with fibromuscular dysplasia: successful treatment with detachable coils. J Vasc Interv Radiol 2009;20:1083-6.
14. Kincaid OW, Davis GD, Hallermann FJ, Hunt JC. Fibromuscular dysplasia of the renal arteries. Arteriographic features, classification, and observations on natural history of the disease. Am J Roentgenol Radium Ther Nucl Med 1968;104:271-82.
15. Begelman SM, Olin JW. Fibromuscular dysplasia. Curr Opin Rheumatol 2000;12:41-7. (Pubitemid 30036686)
16. Stanley JC, Fry WJ, Seeger JF, Hoffman GL, Gabrielsen TO. Extracranial internal carotid and vertebral artery fibrodysplasia. Arch Surg 1974;109:215-22.
17. So EL, Toole JF, Dalal P, Moody DM. Cephalic fibromuscular dysplasia in 32 patients: clinical findings and radiologic features. Arch Neurol 1981;38:619-22.
18. Mettinger KL. Fibromuscular dysplasia and the brain. II. Current concept of the disease. Stroke 1982;13:53-8.
19. Cloft HJ, Kallmes DF, Kallmes MH, Goldstein JH, Jensen ME, Dion JE. Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. J Neurosurg 1998;88:436-40. (Pubitemid 28114715)
20. Stanley JC, Fry WJ. Renovascular hypertension secondary to arterial fibrodysplasia in adults: criteria for operation and results of surgical therapy. Arch Surg 1975;110:922-8.
21. Luscher TF, Lie JT, Stanson AW, Houser OW, Hollier LH, Sheps SG. Arterial fibromuscular dysplasia. Mayo Clin Proc 1987;62:931-52. (Pubitemid 18011660)
22. Stanley JC, Gewertz BL, Renal FWJ. Systemic renin indices and renal vein renin ratios as prognostic indicators in remedial renovascular hypertension. J Surg Res 1976;20:149-55.
23. Rushton AR. The genetics of fibromuscular dysplasia. Arch Intern Med 1980;140:233-6. (Pubitemid 10147667)
24. Perdu J, Boutouyrie P, Bourgain C, Stern N, Laloux B, Bozec E, et al. Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens 2007;21:393-400. (Pubitemid 46646173)
25. Harrison EG Jr, McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc 1971;46: 161-7.
26. McCormack LJ, Poutasse EF, Meaney TF, Noto TJ Jr, Dustan HP. A pathologic-arteriographic correlation of renal arterial disease. Am Heart J 1966;72:188-98.
27. Olin JW. Recognizing and managing fibromuscular dysplasia. Cleve Clin J Med 2007;74:273-82.
28. Olin JW. Syndromes that mimic vasculitis. Curr Opin Cardiol 1991;6: 768-74.
29. Weiner RB, Kiernan TJ, Yan BP, Rosenfield K, Jaff MR. Images in cardiovascular medicine. Adventitial fibromuscular dysplasia of the renal artery: management challenges of nonatherosclerotic renal artery stenosis. Circulation 2009;120:e157-8.
30. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice guidelines (Writing Committee to develop guidelines for the management of patients with peripheral arterial disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus and Vascular Disease Foundation. J Am Coll Cardiol 2006;47:1239-312.
31. Liu PS, Platt JF. Angiography of the renal circulation. Radiol Clin North Am 2010;48:347-65.
32. Anderson CA, Hansen KJ, Benjamin ME, Keith DR, Craven TE, Dean RH. Renal artery fibromuscular dysplasia: results of current surgical therapy. J Vasc Surg 1995;22:207-15.
33. Goncharenko V, Gerlock AJ Jr, Shaff MI, Hollifield JW. Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology 1981;139:45-51. (Pubitemid 11138795)
34. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984;11: 383-92. (Pubitemid 14060862)
35. Corrin LS, Sandok BA, Houser OW. Cerebral ischemic events in patients with carotid artery fibromuscular dysplasia. Arch Neurol 1981; 38:616-8. (Pubitemid 11019170)
36. Mettinger KL, Soderstrom CE. Pathogenetic profile of TIA before 55. A three-year investigation. J Neurol Sci 1978;36:341-8. (Pubitemid 8318687)
37. de Bray JM, Marc G, Pautot V, Vielle B, Pasco A, Lhoste P, et al. Fibromuscular dysplasia may herald symptomatic recurrence of cervical artery dissection. Cerebrovasc Dis 2007;23:448-52.
38. Pate GE, Lowe R, Buller CE. Fibromuscular dysplasia of the coronary and renal arteries? Catheter Cardiovasc Interv 2005;64:138-45.
39. Das CJ, Neyaz Z, Thapa P, Sharma S, Vashist S. Fibromuscular dysplasia of the renal arteries: a radiological review. Int Urol Nephrol 2007; 39:233-8. (Pubitemid 46722971)
40. Prasad A, Zafar N, Mahmud E. Assessment of renal artery fibromuscular dysplasia: angiography, intravascular ultrasound (with virtual histology), and pressure wire measurements. Catheter Cardiovasc Interv 2009;74:260-4.
41. Olin JW. Misconceptions about the diagnosis and treatment of fibromuscular dysplasia. Catheter Cardiovasc Interv 2009;74:265-6.
42. Gowda MS, Loeb AL, Crouse LJ, Kramer PH. Complementary roles of color-flow duplex imaging and intravascular ultrasound in the diagnosis of renal artery fibromuscular dysplasia: should renal arteriography serve as the "gold standard"? J Am Coll Cardiol 2003;41:1305-11.
43. Rubin GD. MDCT imaging of the aorta and peripheral vessels. Eur J Radiol 2003;45(Suppl 1):S42-9.
44. Rubin GD. 3-D imaging with MDCT. Eur J Radiol 2003;45(Suppl 1):S37-41.
45. Olin JW, Piedmonte MR, Young JR, DeAnna S, Grubb M, Childs MB. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med 1995;122: 833-8.
46. Leung DA, Hoffmann U, Pfammatter T, Hany TF, Rainoni L, Hilfiker P, et al. Magnetic resonance angiography versus duplex sonography for diagnosing renovascular disease. Hypertension 1999;33:726-31. (Pubitemid 29091656)
47. Carman TL, Olin JW, Czum J. Noninvasive imaging of the renal arteries. Urol Clin North Am 2001;28:815-26. (Pubitemid 34028044)
48. Jayawardene S, Reidy J, Scoble J. Clinical picture: ipsilateral atherosclerotic and fibromuscular renal artery stenosis. Lancet 2000;356:2138. (Pubitemid 32047950)
49. Aqel R, Gupta R, Zoghbi G. Coexistent fibromuscular dysplasia and atherosclerotic renal artery stenosis. J Invasive Cardiol 2005;17:572-3.
50. Aqel R, AlJaroudi WW, Hage FG, Nanda NC. Renal artery fibromuscular dysplasia is a cause of refractory hypertension in the elderly. Echocardiography 2009;26:109-10.
51. Slavin RE. Segmental arterial mediolysis: course, sequelae, prognosis, and pathologic-radiologic correlation. Cardiovasc Pathol 2009; 18:352-60.
52. Slavin RE, Inada K. Segmental arterial mediolysis with accompanying venous angiopathy: a clinical pathologic review, report of 3 new cases, and comments on the role of endothelin-1 in its pathogenesis. Int J Surg Pathol 2007;15:121-34. (Pubitemid 46548096)
53. Slavin RE, Saeki K, Bhagavan B, Maas AE. Segmental arterial mediolysis: a precursor to fibromuscular dysplasia? Mod Pathol 1995;8:287-94.
54. Inada K, Maeda M, Ikeda T. Segmental arterial mediolysis: unrecognized cases culled from cases of ruptured aneurysm of abdominal visceral arteries reported in the Japanese literature. Pathol Res Pract 2007;203:771-8. (Pubitemid 47543530)
55. Schievink WI, Bjornsson J, Piepgras DG. Coexistence of fibromuscular dysplasia and cystic medial necrosis in a patient with Marfan's syndrome and bilateral carotid artery dissections. Stroke 1994;25:2492-6. (Pubitemid 24359325)
56. Janzen J, Vuong PN, Rothenberger-Janzen K. Takayasu's arteritis and fibromuscular dysplasia as causes of acquired atypical coarctation of the aorta: retrospective analysis of seven cases. Heart Vessels 1999;14:277-82. (Pubitemid 30342827)
57. D'Souza SJ, Tsai WS, Silver MM, Chait P, Benson LN, Silverman E, et al. Diagnosis and management of stenotic aorto-arteriopathy in childhood. J Pediatr 1998;132:1016-22. (Pubitemid 28280416)
58. Bol A, Missault L, Dewilde W. Renovascular hypertension associated with neurofibromatosis: a case report. Acta Clin Belg 2007;62:61-3. (Pubitemid 46512953)
59. Nopajaroonsri C, Lurie AA. Venous aneurysm, arterial dysplasia, and near-fatal hemorrhages in neurofibromatosis type. 1. Hum Pathol 1996;27:982-5.
60. Vuong PN, Le Bourgeois P, Houissa-Vuong S, Martin P, Berrod JL. [Intimal muscular fibrodysplasia responsible for an ischemic gastric ulcer in a patient with a von Recklinghausen's disease: a case report]. J Mal Vasc 2001;26:65-8.
61. Schievink WI, Limburg M. Angiographic abnormalities mimicking fibromuscular dysplasia in a patient with Ehlers-Danlos syndrome, type. IV. Neurosurgery 1989;25:482-3.
62. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-71.
63. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg 2008;48:865-71.
64. Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin PF. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 2010;56:525-32.
65. Mahmud E, Brocato M, Palakodeti V, Tsimikas S. Fibromuscular dysplasia of renal arteries: percutaneous revascularization based on hemodynamic assessment with a pressure measurement guidewire. Catheter Cardiovasc Interv 2006;67:434-7. (Pubitemid 43346749)
66. Sperati CJ, Aggarwal N, Arepally A, Atta MG. Fibromuscular dysplasia. Kidney Int 2008;75:333-6.
67. Mounier-Vehier C, Lions C, Jaboureck O, Devos P, Haulon S, Wibaux M, et al. Parenchymal consequences of fibromuscular dysplasia renal artery stenosis. Am J Kidney Dis 2002;40:1138-45. (Pubitemid 35403124)
68. Mounier-Vehier C, Haulon S, Devos P, Lions C, Jaboureck O, Gaxotte V, et al. Renal atrophy outcome after revascularization in fibromuscular dysplasia disease. J Endovasc Ther 2002;9:605-13. (Pubitemid 35416818)
69. De Martino RR, Stone DH. Repair of multiple right renal artery aneurysms with associated fibromuscular dysplasia in a solitary kidney. J Vasc Surg 2009;49:497.
70. Sos TA, Pickering TG, Sniderman K, Saddekni S, Case DB, Silane MF, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983;309:274-9. (Pubitemid 13026964)
71. Baert AL, Wilms G, Amery A, Vermylen J, Suy R. Percutaneous transluminal renal angioplasty: initial results and long-term follow-up in 202 patients. Cardiovasc Intervent Radiol 1990;13:22-8. (Pubitemid 20147665)
72. Tegtmeyer CJ, Selby JB, Hartwell GD, Ayers C, Tegtmeyer V. Results and complications of angioplasty in fibromuscular disease. Circulation 1991;83(2 Suppl):I155-61.
73. Bonelli FS, McKusick MA, Textor SC, Kos PB, Stanson AW, Johnson CM, et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc 1995;70:1041-52.
74. Jensen G, Zachrisson BF, Delin K, Volkmann R, Aurell M. Treatment of renovascular hypertension: one-year results of renal angioplasty. Kidney Int 1995;48:1936-45.
75. Davidson RA, Barri Y, Wilcox CS. Predictors of cure of hypertension in fibromuscular renovascular disease. Am J Kidney Dis 1996;28:334-8. (Pubitemid 26304411)
76. Klow NE, Paulsen D, Vatne K, Rokstad B, Lien B, Fauchald P. Percutaneous transluminal renal artery angioplasty using the coaxial technique. Ten years of experience from 591 procedures in 419 patients. Acta Radiol 1998;39:594-603.
77. Birrer M, Do DD, Mahler F, Triller J, Baumgartner I. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg 2002;23:146-52. (Pubitemid 41079478)
78. Surowiec SM, Sivamurthy N, Rhodes JM, Lee DE, Waldman DL, Green RM, et al. Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg 2003;17:650-5. (Pubitemid 37553488)
79. De Fraissinette B, Garcier JM, Dieu V, Mofid R, Ravel A, Boire JY, et al. Percutaneous transluminal angioplasty of dysplastic stenoses of the renal artery: results on 70 adults. Cardiovasc Intervent Radiol 2003;26:46-51. (Pubitemid 36919573)
80. Kim HJ, Do YS, Shin SW, Park KB, Cho SK, Choe YH, et al. Percutaneous transluminal angioplasty of renal artery fibromuscular dysplasia: mid-term results. Korean J Radiol 2008;9:38-44.
81. Mouse M, Sabri SS, Park A, Saad WEA, Angle JF, Matsumoto AH. Treatment of renal artery fibromuscular dysplasia. Technol Vascul Intervent Radiol 2010;13:126-33.
82. Barrier P, Julien A, Guillaume C, Philippe O, Herve R, Francis J. Technical and clinical results after percutaneous angioplasty in nonmedial fibromuscular dysplasia: outcome after endovascular management of unifocal renal artery stenoses in 30 patients. Cardiovasc Intervent Radiol 2010;33:270-7.
83. Wells RP, Smith RR. Fibromuscular dysplasia of the internal carotid artery: a long term follow-up. Neurosurgery 1982;10:39-43. (Pubitemid 12212272)
84. Stewart MT, Moritz MW, Smith RB III, Fulenwider JT, Perdue GD. The natural history of carotid fibromuscular dysplasia. J Vasc Surg 1986;3:305-10. (Pubitemid 16159811)
85. Belan A, Vesela M, Vanek I, Weiss K, Peregrin JH. Percutaneous transluminal angioplasty of fibromuscular dysplasia of the internal carotid artery. Cardiovasc Intervent Radiol 1982;5:79-81. (Pubitemid 12090404)
86. Wilms GE, Smits J, Baert AL, De Wolf L. Percutaneous transluminal angioplasty in fibromuscular dysplasia of the internal carotid artery: one year clinical and morphological follow-up. Cardiovasc Intervent Radiol 1985;8:20-3. (Pubitemid 15000934)
87. Welch EL, Lemkin JA, Geary JE. Gruntzig balloon dilation for fibromuscular dysplasia of the internal carotid arteries. N Y State J Med 1985;85:115-7. (Pubitemid 15076717)
88. Tsai FY, Matovich V, Hieshima G, Shah DC, Mehringer CM, Tiu G, et al. Percutaneous transluminal angioplasty of the carotid artery. AJNR Am J Neuroradiol 1986;7:349-58. (Pubitemid 16153108)
89. Olin JW. Carotid artery fibromuscular dysplasia. Am J Surg 2007;194: 419.
90. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 2001;344:898-906. (Pubitemid 32224399)
91. Edgell RC, Abou-Chebl A, Yadav JS. Endovascular management of spontaneous carotid artery dissection. J Vasc Surg 2005;42: 854-60. (Pubitemid 41571947)
92. Yoshida T, Ohashi I, Suzuki S, Iwai T. Fibromuscular disease of the brachial artery with digital emboli treated effectively by transluminal angioplasty. Cardiovasc Intervent Radiol 1994;17:99-101. (Pubitemid 24093729)
93. Yamaguchi R, Yamaguchi A, Isogai M, Hori A, Kin Y. Fibromuscular dysplasia of the visceral arteries. Am J Gastroenterol 1996;91: 1635-8. (Pubitemid 26269185)
94. Guill CK, Benavides DC, Rees C, Fenves AZ, Burton EC. Fatal mesenteric fibromuscular dysplasia: a case report and review of the literature. Arch Intern Med 2004;164:1148-53. (Pubitemid 38668996)
95. Camuglia A, Manins V, Taylor A, Hengel C. Case report and review: epicardial coronary artery fibromuscular dysplasia. Heart Lung Circ 2009;18:151-4.
96. Burton TM. The 'rare' disease that isn't. Wall Street J June 27, 2009: A-1.